A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)

Ryohei Kawabata(Osaka International Cancer Institute), Masashi Fujii(Nihon University), Jun Hihara(Hiroshima City Asa Citizens Hospital), Mizutomo Azuma(Kitasato University Hospital), Hirofumi Michimae(Kitasato University), Yu Sunakawa(St. Marianna University School of Medicine), Dai Manaka(Kyoto Katsura Hospital), Masazumi Takahashi(Yokohama Municipal Citizen's Hospital), Hiroo Katsuya(Saga University), Takahisa Suzuki(National Hospital Organization), Naoki Izawa(St. Marianna University School of Medicine), Shigenori Kadowaki(Aichi Cancer Center), Yuji Negoro(University of Kochi), Akihito Tsuji(Kagawa University Hospital), Yoshio Nagahisa(Kurashiki Central Hospital), Kazuhiro Nishikawa(Osaka National Hospital), Takao Takahashi(Maruyama Memorial General Hospital), Mitsugu Kochi(International University of Health and Welfare), Masato Nakamura(Chiba University), Atsushi Ishiguro(Teine Keijinkai Hospital), Wataru Ichikawa(Showa University Fujigaoka Hospital)
Targeted Oncology
April 15, 2023
Cited by 5


Related Papers